Top compounds associated with response to A4GALT


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0005
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.086 0.01
mRNA temsirolimus FIMM pan-cancer AAC 0.26 0.1
mRNA temsirolimus GDSC1000 pan-cancer AAC 0.043 0.2
mRNA temsirolimus CTRPv2 pan-cancer AAC 0.034 0.5
mRNA thalidomide CTRPv2 pan-cancer AAC 0.074 0.2
mRNA thapsigargin gCSI pan-cancer AAC 0.04 0.5
mRNA thapsigargin GDSC1000 pan-cancer AAC 0.017 0.6
mRNA tigecycline CTRPv2 pan-cancer AAC -0.049 0.3
mRNA tipifarnib CTRPv2 pan-cancer AAC -0.053 0.1
Download CSV